Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Diabetes tablet that makes the kidneys pass out extra sugar. | SGLT2 inhibitor for diabetes, heart failure and kidney disease. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | SGLT2 inhibitors | SGLT2 inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | Type 2 diabetes, Diabetic kidney disease, Heart failure risk reduction | Type 2 diabetes, Heart failure (all ejection fractions), Chronic kidney disease |
| How it works | Stops the kidneys reclaiming some filtered sugar, so it leaves in urine. | Pushes excess sugar and salt out through the urine. |
| Starts working | — | — |
| Half-life | — | About 13 hours |
| Typical adult dose | Usually 100 mg once daily before the first meal; some people may increase to 300 mg if kidney function allows. | 10 mg once a day. |
| Forms | Tablet | Tablet, Combination tablets |
| Common side effects | Genital thrush, Increased urination, Dehydration | Genital thrush, Urinary infections, Back pain |
| Serious side effects | Diabetic ketoacidosis, Severe urinary or genital infection, Amputation risk in selected high-risk patients | Ketoacidosis, Dehydration, Fournier's gangrene (rare) |
| Don't take if | — | Type 1 diabetes (risk of ketoacidosis); Severe dehydration or ongoing vomiting; Recurrent genital or urinary infections |
| Alcohol | — | Best to limit. Heavy drinking raises the risk of ketoacidosis. |
| Pregnancy | Usually avoidedNot recommended during pregnancy because fetal kidney development may be affected. | Usually avoidedNot recommended. |
| Breastfeeding | — | Usually avoidedAvoid. |
| In use since | — | 2012 |
| Brand names | United States: InvokanaUnited Kingdom: Invokana | United States: FarxigaUnited Kingdom: ForxigaIndia: Forxiga, Oxra, Udapa |
| Legal status | — | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BK02 | A10BK01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker